Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.

Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.

Why Weight Loss Drugs May Not Work

While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:

1. Genetic and Hormonal Variability

Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.

2. Underlying Medical Conditions

Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.

3. Unrealistic Expectations

Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.

Why it is Important to Identify Non-responders

For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.

For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.

Alternative Treatment Options

When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:

1. Switching to Another GLP-1 Drug

For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.

2. Use of Older Medications

While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.

3. Lifestyle Changes

Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.

4. Medical Management of Obesity

It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.

Why Side Effects of Weight Loss Drug Ozempic May Be a Barrier

For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.

Long-term effects of Ozempic or Wegovy on the Brain

Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.

This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.

While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.

The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.

An antibiotic routinely used for acne has been linked to a lower likelihood of developing schizophrenia. A new investigation from the University of Edinburgh found that adolescents receiving mental health care who were given doxycycline had a reduced chance of being diagnosed with schizophrenia as adults, compared with those who were prescribed other antibiotics.

Although these early findings cannot confirm that doxycycline prevents schizophrenia, the researchers suggest that its influence on immune activity, inflammation, and programmed cell death may help protect the brain from changes associated with the disorder. “Because this research relies on observational records, it cannot prove that doxycycline directly lowers the risk of schizophrenia, so more studies are needed,” the authors explain.

“Even so, the results raise the possibility that doxycycline could play a role in lowering schizophrenia risk among young psychiatric patients and open new avenues for prevention-focused mental health research.”

What Is Schizophrenia?

Schizophrenia is a severe psychiatric disorder that affects about 23 million people worldwide, with most cases identified during late adolescence or early adulthood. The illness can appear suddenly and may bring on psychosis. Typical symptoms include ongoing delusions, hallucinations, disorganized thoughts, restlessness, or withdrawal from others. According to the World Health Organization (WHO), more than two out of three people experiencing psychosis lack access to specialized mental health services.

What Is Doxycycline?

Doxycycline is a broad-acting antibiotic commonly given to teenagers for acne. Some recent research suggests it may also offer certain protective effects for the brain, as it is able to cross the blood-brain barrier. In 2024, Science Alert reported on a Danish study showing that this brain-penetrating antibiotic was associated with a lower likelihood of schizophrenia patients later receiving disability benefits, hinting at how the illness might affect their daily functioning.

To explore this further, child and adolescent psychiatrist Ian Kelleher from the University of Edinburgh led a large international team in reviewing data from more than 56,000 people born in Finland between 1987 and 1997. All had used mental health services in their youth and had been prescribed antibiotics during that time.

The analysis showed that those given doxycycline had a 30 to 35 percent lower chance of developing schizophrenia over the following decade, compared with individuals who had taken other antibiotics. The risk dropped from 2.1 percent in the non-doxycycline group to 1.4 percent in those who used doxycycline.

Doxycycline Linked To A Drop in Schizophrenia Risk

The research team found that taking doxycycline was linked to a 30 to 35 percent reduction in schizophrenia diagnoses over ten years. One theory is that doxycycline may clear an infectious agent that contributes to schizophrenia. Another possibility is that it directly affects inflammation and nerve pathways inside the brain.

Other antibiotics offer hints as well. A 2019 study using stem cells from people with schizophrenia and healthy volunteers showed that minocycline can reduce excessive loss of synapses, a process thought to play a part in schizophrenia. Since both minocycline and doxycycline belong to the tetracycline family, they may share similar properties. Using Finland’s health records, Kelleher’s team noted that nearly half of all psychotic disorders in the population occurred in individuals who had visited adolescent psychiatric services.

The researchers believe this stage of life may offer a valuable period for early intervention, where medications like doxycycline might help reduce the chance of the illness progressing. “Nearly half of the people who develop schizophrenia had earlier contact with child and adolescent mental health services for other issues,” Kelleher says.

“At the moment, we do not have any proven ways to lower the risk of schizophrenia in these young people, which makes these findings encouraging.”

Does Doxycycline Have Side Effects?

Doxycycline is available in two forms, doxycycline monohydrate and doxycycline hyclate, though both tend to cause similar reactions. This list does not include every possible side effect, so consult your medical provider if you are unsure about anything you notice while taking the medication.

Mild doxycycline side effects include:

• Nausea or vomiting
• Diarrhea
• Sensitivity to sunlight
• Sore throat or difficulty swallowing
• Vaginal yeast infection
• Itchy skin and rash (urticaria)

Rare but serious doxycycline side effects include:

• Ulcers in the esophagus
• Severe skin reactions
• Liver problems
• Tooth discoloration in children
• Clostridioides difficile (C. diff) diarrhea
• Intracranial hypertension (increased pressure around the brain)
• Low blood cell counts

Always speak with your healthcare professional before starting or stopping any medication.

California-based Dr. Salvador Plasencia, who supplied 20 vials of ketamine to Matthew Perry, the Friends (1994–2004) star, has been sentenced to 30 months in prison. Perry, 54, was discovered dead in his luxurious Los Angeles home on October 28, 2023. The actor had a history of depression and substance use but was reportedly on the path to recovery. His final on-screen appearance was playing himself in the 2021 feature-length special, *Friends: The Reunion*.

Perry accidentally drowned due to the acute effects of a ketamine overdose. Five individuals faced charges in the case, all of whom eventually pleaded guilty. Dr. Plasencia is the first person to be sentenced in connection with Perry’s death. In addition to his 30-month prison term, he was ordered to pay a fine of $5,600. But what exactly is ketamine, and how can an overdose affect the body?

Doctor Who Supplied Matthew Perry Ketamine Pleads Guilty

Perry was found dead in his hot tub on October 28, 2023, at age 54. The LA County Medical Examiner determined that his death resulted from the “acute effects of ketamine,” with contributing factors including drowning and coronary artery disease. In July 2025, Dr. Plasencia pleaded guilty to felony charges for distributing ketamine to four individuals. He also confirmed that Perry had received multiple doses of the drug prior to his death. Perry’s death in Los Angeles, California, was officially attributed to the “acute effects of ketamine,” which caused him to lose consciousness and drown in his hot tub. He had struggled with substance abuse for years and had been receiving ketamine treatment for anxiety and depression at an accredited clinic, according to the BBC.

What Is Ketamine?

Ketamine is a medication used by doctors as an anesthetic to induce temporary loss of consciousness. Under the Controlled Substances Act, it is classified as a Schedule III non-narcotic substance. The FDA has approved ketamine for use only as a general anesthetic. However, in some cases, doctors prescribe it “off-label” for conditions such as depression. “Off-label” refers to using a drug for a condition that the FDA has not specifically approved.

How Does Ketamine Overdose Harm Your Body?

Certain medical conditions can make ketamine overdose riskier. People with heart disease or high blood pressure may experience increased intracranial pressure, raising the chance of stroke. Blood flow to the heart can be reduced. As a relaxant, excessive ketamine can interfere with breathing, causing it to become shallow. High doses can also be toxic to the liver and urinary bladder. Unregulated or repeated use may lead to dependence and increase the risk of developing schizophrenia.

Side Effects Of Ketamine

At prescribed doses, common side effects of ketamine, according to Medical News Today, include:

• Drowsiness
• Double vision
• Confusion
• Nausea
• Vomiting
• Dizziness
• A general feeling of unease

Ketamine can also cause a wide range of other symptoms affecting different parts of the body, though these are less frequent.

Ketamine As A Drug Of Abuse

Ketamine can produce sensations of detachment from the environment, pain relief, and hallucinations, which has led to its misuse. Recreational users often describe feelings of being separated from their body or a floating sensation. Some report near-total sensory detachment, which they compare to a near-death experience.

The drug is particularly popular among teens and young adults in club settings. Many users prefer ketamine trips to PCP or LSD because the hallucinations are shorter—lasting 30 minutes to an hour—rather than several hours.

Always consult a healthcare professional before starting, stopping, or changing any medication.

As December rolls in, familiar melodies float through malls, train stations and sometimes right outside your front door. Carol groups wrapped in tinsel bring a warm sense of nostalgia. Their voices rise in unison, cheerful and bright, filling cold evenings with a comfort that feels almost instinctive. What most people do not realize is that this seasonal tradition may be giving the singers themselves a genuine health lift.

Researchers have been exploring this for years, and their findings suggest that singing is far more than a joyful holiday hobby. It strengthens social bonds, supports emotional wellbeing and even offers physical benefits that reach deep into the brain and lungs.

Why Singing Feels So Good

Alex Street, a researcher at the Cambridge Institute for Music Therapy Research, describes singing as a cognitive, physical, emotional and social act, as reported by BBC. When people sing, especially in groups, the brain lights up in ways few other activities can replicate. Regions responsible for language, movement and emotion get activated at the same time. The steady breathing that singing requires also prompts the release of endorphins, which brings on feelings of pleasure and reduces pain.

Psychologists have long noted how even strangers can develop a sense of togetherness after singing side by side for just an hour. This may explain why community choirs often feel like extended families.

A Simple Workout with Surprising Benefits

Beyond the emotional high, singing demands more from the body than many expect. Studies have shown that it can improve heart rate, circulation and blood pressure. The controlled breathing and longer exhalations strengthen the lungs in ways similar to moderate physical activity. Some researchers even compare a singing session with a brisk walk.

BBC reports that Adam Lewis, an associate professor of respiratory physiotherapy at the University of Southampton, notes that singing encourages people to use their respiratory muscles more efficiently. This is one reason why it has become a useful complementary tool for people living with chronic lung conditions.

Healing Through Harmony

One of the most profound uses of singing is in therapy for people recovering from brain injuries or neurological illnesses. Music therapists often rely on songs from childhood to help patients regain speech or movement. The story of former US congresswoman Gabrielle Giffords is one of the most well known examples, reports BBC. After surviving a severe brain injury, she regained her speech partly through singing familiar melodies during therapy sessions.

Similar approaches have been used with stroke survivors, patients with Parkinson’s disease and people living with dementia. Singing provides repeated vocal practice, encourages focus, and stimulates both sides of the brain. Experts also believe that it may help slow cognitive decline in older adults, although long term studies are still needed.

A Gentle Way Back to Community

For many people living with chronic illness, joining a choir brings something even more meaningful than physical gains. It offers a space where patients, caregivers and professionals participate as equals. Street describes these shared moments as a rare kind of unity that dissolves labels and replaces them with a sense of belonging.

As researchers learn more about the power of song, the message becomes clearer. Singing is not just entertainment. It is a tool for connection, a low cost therapy and a way to strengthen both mind and body. So this festive season, joining a group around the Christmas tree might be more beneficial than you think.